Short answer · Medically reviewed summary · Last updated: 2026-04-07
Schnitzler syndrome is a rare autoinflammatory disorder characterized by chronic urticaria, intermittent fever, bone pain, and the presence of a monoclonal IgM gammopathy. While it is almost exclusively referred to as Schnitzler syndrome in modern clinical literature, it is occasionally identified in older medical texts as chronic urticaria with monoclonal gammopathy, and it is classified under the Orphanet identifier ORPHA:3145. What are the alternative names for Schnitzler syndrome? In contemporary medical practice, Schnitzler syndrome is the universally accepted term.
Schnitzler syndrome is a rare autoinflammatory disorder characterized by chronic urticaria, intermittent fever, bone pain, and the presence of a monoclonal IgM gammopathy. While it is almost exclusively referred to as Schnitzler syndrome in modern clinical literature, it is occasionally identified in older medical texts as chronic urticaria with monoclonal gammopathy, and it is classified under the Orphanet identifier ORPHA:3145.
In contemporary medical practice, Schnitzler syndrome is the universally accepted term. Because the condition was first described by the French dermatologist Liliane Schnitzler in 1972, it bears her name as an eponym. You may encounter the following terms or descriptions in older medical records or international literature:
The naming of Schnitzler syndrome reflects the evolution of our understanding of autoinflammatory conditions. Historically, clinicians described the disease based solely on its observable clinical manifestations: a persistent, non-pruritic urticarial rash paired with the laboratory finding of an IgM protein spike. As the medical community recognized that these symptoms constituted a distinct clinical entity rather than separate, coincidental findings, the eponym Schnitzler syndrome became the standard nomenclature. Today, the medical community prefers this name to distinguish it from other forms of urticarial vasculitis and various plasma cell dyscrasias.
Standardized classification systems help ensure that patients and providers can access consistent data globally. Schnitzler syndrome is recognized in the following major databases:
There are no significant regional differences in the naming of Schnitzler syndrome. Whether in North America, Europe, or Asia, the eponym Schnitzler syndrome is the standard term used in peer-reviewed journals, clinical guidelines, and international conferences. Using this specific name is the most effective way to search for the latest research, clinical trials, and patient support resources, including the 54 members currently sharing their experiences on DiseaseMaps.org.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.